Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
The Global En Bloc Resection of Bladder Tumour Registry
- Status
- RECRUITING
- Phase
- N/A
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- Status
- RECRUITING
- Phase
- N/A
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Improving Care for Rural Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- NA
Robotic Radical Cystectomy Outcomes
- Status
- RECRUITING
- Phase
- N/A
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
- Status
- COMPLETED
- Phase
- N/A
Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
- Status
- TERMINATED
- Phase
- PHASE2
Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder
- Status
- UNKNOWN
- Phase
- PHASE2
Prognostic Biomarkers in Patients With Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT
- Status
- UNKNOWN
- Phase
- NA
Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
- Status
- COMPLETED
- Phase
- NA
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
- Status
- COMPLETED
- Phase
- N/A
Immunological Response of Bladder Cancer Patients Under BCG
- Status
- COMPLETED
- Phase
- PHASE3
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
- Status
- TERMINATED
- Phase
- NA
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
- Status
- UNKNOWN
- Phase
- N/A
Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates
- Status
- COMPLETED
- Phase
- NA